Gene · 7296
Papers4,270
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,181 to 1,200 of 4,270
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Construction of a stable TrxR1 knockout HCT-116 cell line using CRISPR/Cas9 gene editing system]. | Sheng Wu Gong Cheng Xue Bao | 2022 | 35355475 | PubTator, text mining | PubMed |
| Cytotoxic and Radiosensitising Effects of a Novel Thioredoxin Reductase Inhibitor in Brain Cancers. | Mol Neurobiol | 2022 | 35344158 | PubTator, text mining | PubMed |
| Behavioral profile of vitamin B12 deficiency: A reflection of impaired brain development, neuronal stress and altered neuroplasticity. | Vitam Horm | 2022 | 35337627 | PubTator, text mining | PubMed |
| Oxidative Stress in Arterial Hypertension (HTN): The Nuclear Factor Erythroid Factor 2-Related Factor 2 (Nrf2) Pathway, Implications and Future Perspectives. | Pharmaceutics | 2022 | 35335911 | PubTator, text mining | PubMed |
| Discovery of Proteins Responsible for Resistance to Three Chemotherapy Drugs in Breast Cancer Cells Using Proteomics and Bioinformatics Analysis. | Molecules | 2022 | 35335125 | PubTator, text mining | PubMed |
| Proteomic Alterations in Follicular Fluid of Human Small Antral Follicles Collected from Polycystic Ovaries-A Pilot Study. | Life (Basel) | 2022 | 35330141 | PubTator, text mining | PubMed |
| Proteomic Studies of Psoriasis. | Biomedicines | 2022 | 35327421 | PubTator, text mining | PubMed |
| NRF2 and Key Transcriptional Targets in Melanoma Redox Manipulation. | Cancers (Basel) | 2022 | 35326683 | PubTator, text mining | PubMed |
| A Systematic Review to Define the Multi-Faceted Role of Lysine Methyltransferase SETD7 in Cancer. | Cancers (Basel) | 2022 | 35326563 | PubTator, text mining | PubMed |
| Activation of the Nrf2 Pathway Prevents Mitochondrial Dysfunction Induced by Caspase-3 Cleaved Tau: Implications for Alzheimer's Disease. | Antioxidants (Basel) | 2022 | 35326165 | PubTator, text mining | PubMed |
| Characterization of H2O2-Induced Alterations in Global Transcription of mRNA and lncRNA. | Antioxidants (Basel) | 2022 | 35326145 | PubTator, text mining | PubMed |
| Shedding a New Light on Skin Aging, Iron- and Redox-Homeostasis and Emerging Natural Antioxidants. | Antioxidants (Basel) | 2022 | 35326121 | PubTator, text mining | PubMed |
| Redox-Related Proteins in Melanoma Progression. | Antioxidants (Basel) | 2022 | 35326089 | PubTator, text mining | PubMed |
| A novel mTOR-associated gene signature for predicting prognosis and evaluating tumor immune microenvironment in lung adenocarcinoma. | Comput Biol Med | 2022 | 35325730 | PubTator, text mining | PubMed |
| Pharmacogenomics of cisplatin-induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy. | Cancer Med | 2022 | 35322580 | PubTator, text mining | PubMed |
| Construction of a Novel Ferroptosis-Related Gene Signature for Predicting Survival of Patients With Lung Adenocarcinoma. | Front Oncol | 2022 | 35311093 | PubTator, text mining | PubMed |
| Potential Role of APEX1 During Ferroptosis. | Front Oncol | 2022 | 35311089 | PubTator, text mining | PubMed |
| Identification of the Signature Genes and Network of Reactive Oxygen Species Related Genes and DNA Repair Genes in Lung Adenocarcinoma. | Front Med (Lausanne) | 2022 | 35308531 | PubTator, text mining | PubMed |
| Morphine-induced modulation of Nrf2-antioxidant response element signaling pathway in primary human brain microvascular endothelial cells. | Sci Rep | 2022 | 35301408 | PubTator, text mining | PubMed |
| Cadmium acute exposure induces metabolic and transcriptomic perturbations in human mature adipocytes. | Toxicology | 2022 | 35301059 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7296/papers?page=60